Literature DB >> 19896376

New small molecule inhibitors of hepatitis C virus.

Wanguo Wei1, Cuifang Cai, Smitha Kota, Virginia Takahashi, Feng Ni, A Donny Strosberg, John K Snyder.   

Abstract

New small molecule inhibitors of HCV were discovered by screening a small library of indoline alkaloid-type compounds. An automated assay format was employed which allowed identification of dimerization inhibitors of core, the capsid protein of the virus. These compounds were subsequently shown to block production of infectious virus in hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19896376      PMCID: PMC2783740          DOI: 10.1016/j.bmcl.2009.10.070

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  12 in total

Review 1.  Small-molecule inhibitors of protein-protein interactions: progressing towards the dream.

Authors:  Michelle R Arkin; James A Wells
Journal:  Nat Rev Drug Discov       Date:  2004-04       Impact factor: 84.694

Review 2.  Protein-protein interactions as targets for small molecule drug discovery.

Authors:  David C Fry
Journal:  Biopolymers       Date:  2006       Impact factor: 2.505

3.  An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus.

Authors:  Daniel Lamarre; Paul C Anderson; Murray Bailey; Pierre Beaulieu; Gordon Bolger; Pierre Bonneau; Michael Bös; Dale R Cameron; Mireille Cartier; Michael G Cordingley; Anne-Marie Faucher; Nathalie Goudreau; Stephen H Kawai; George Kukolj; Lisette Lagacé; Steven R LaPlante; Hans Narjes; Marc-André Poupart; Jean Rancourt; Roel E Sentjens; Roger St George; Bruno Simoneau; Gerhard Steinmann; Diane Thibeault; Youla S Tsantrizos; Steven M Weldon; Chan-Loi Yong; Montse Llinàs-Brunet
Journal:  Nature       Date:  2003-10-26       Impact factor: 49.962

4.  Peptide inhibitors of hepatitis C virus core oligomerization and virus production.

Authors:  S Kota; C Coito; G Mousseau; J-P Lavergne; A D Strosberg
Journal:  J Gen Virol       Date:  2009-03-04       Impact factor: 3.891

Review 5.  Hepatitis C in the HIV-infected patient.

Authors:  Barbara H McGovern
Journal:  J Acquir Immune Defic Syndr       Date:  2007-07-01       Impact factor: 3.731

Review 6.  Hepatitis C virus genetic variability in patients undergoing antiviral therapy.

Authors:  Juan Cristina; María del Pilar Moreno; Gonzalo Moratorio
Journal:  Virus Res       Date:  2007-04-20       Impact factor: 3.303

Review 7.  Small molecule protein-protein inhibitors for the p53-MDM2 interaction.

Authors:  Anna S Dudkina; Craig W Lindsley
Journal:  Curr Top Med Chem       Date:  2007       Impact factor: 3.295

Review 8.  Genetic diversity and evolution of hepatitis C virus--15 years on.

Authors:  Peter Simmonds
Journal:  J Gen Virol       Date:  2004-11       Impact factor: 3.891

Review 9.  Hepatitis C virus biology.

Authors:  C Giannini; C Bréchot
Journal:  Cell Death Differ       Date:  2003-01       Impact factor: 15.828

Review 10.  Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus.

Authors:  Raffaele De Francesco; Andrea Carfí
Journal:  Adv Drug Deliv Rev       Date:  2007-08-11       Impact factor: 15.470

View more
  7 in total

Review 1.  Comprehensive survey of chemical libraries for drug discovery and chemical biology: 2009.

Authors:  Roland E Dolle; Bertrand Le Bourdonnec; Karin Worm; Guillermo A Morales; Craig J Thomas; Wei Zhang
Journal:  J Comb Chem       Date:  2010-10-05

2.  Discovery of new antimalarial chemotypes through chemical methodology and library development.

Authors:  Lauren E Brown; Ken Chih-Chien Cheng; Wan-Guo Wei; Pingwei Yuan; Peng Dai; Richard Trilles; Feng Ni; Jing Yuan; Ryan MacArthur; Rajarshi Guha; Ronald L Johnson; Xin-zhuan Su; Melissa M Dominguez; John K Snyder; Aaron B Beeler; Scott E Schaus; James Inglese; John A Porco
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-15       Impact factor: 11.205

3.  Potent inhibitors of hepatitis C core dimerization as new leads for anti-hepatitis C agents.

Authors:  Feng Ni; Smitha Kota; Virginia Takahashi; A Donny Strosberg; John K Snyder
Journal:  Bioorg Med Chem Lett       Date:  2011-04-15       Impact factor: 2.823

4.  Identification of a broad-spectrum inhibitor of viral RNA synthesis: validation of a prototype virus-based approach.

Authors:  Claire Marie Filone; Erin N Hodges; Brian Honeyman; G Guy Bushkin; Karla Boyd; Andrew Platt; Feng Ni; Kyle Strom; Lisa Hensley; John K Snyder; John H Connor
Journal:  Chem Biol       Date:  2013-03-21

5.  Dimerization-driven interaction of hepatitis C virus core protein with NS3 helicase.

Authors:  G Mousseau; S Kota; V Takahashi; D N Frick; A D Strosberg
Journal:  J Gen Virol       Date:  2010-09-29       Impact factor: 3.891

6.  Core as a novel viral target for hepatitis C drugs.

Authors:  Arthur Donny Strosberg; Smitha Kota; Virginia Takahashi; John K Snyder; Guillaume Mousseau
Journal:  Viruses       Date:  2010-08-20       Impact factor: 5.818

7.  Direct binding of a hepatitis C virus inhibitor to the viral capsid protein.

Authors:  Smitha Kota; Virginia Takahashi; Feng Ni; John K Snyder; A Donny Strosberg
Journal:  PLoS One       Date:  2012-02-28       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.